Michael Kilian

1.6k total citations · 1 hit paper
15 papers, 253 citations indexed

About

Michael Kilian is a scholar working on Immunology, Oncology and Genetics. According to data from OpenAlex, Michael Kilian has authored 15 papers receiving a total of 253 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 9 papers in Oncology and 4 papers in Genetics. Recurrent topics in Michael Kilian's work include Immunotherapy and Immune Responses (10 papers), CAR-T cell therapy research (7 papers) and Glioma Diagnosis and Treatment (4 papers). Michael Kilian is often cited by papers focused on Immunotherapy and Immune Responses (10 papers), CAR-T cell therapy research (7 papers) and Glioma Diagnosis and Treatment (4 papers). Michael Kilian collaborates with scholars based in Germany, United States and Australia. Michael Kilian's co-authors include Michael Platten, Lukas Bunse, Mirco Friedrich, Roman Sankowski, Theresa Bunse, Ranjan Maity, Marc‐Steffen Raab, Hartmut Goldschmidt, Wolfgang Wick and Carsten Müller‐Tidow and has published in prestigious journals such as Nature Communications, Cancer Cell and International Journal of Molecular Sciences.

In The Last Decade

Michael Kilian

15 papers receiving 251 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The pre-existing T cell landscape determines the response to bispecific T cell engagers in multiple myeloma patients

2023 131 citations Mirco Friedrich, Paola Neri et al. Cancer Cell profile →

Peers

Michael Kilian

ONCOL

IMMUN

MB

GENET

HEMAT

Veronika Lysenko Switzerland

Juan C. Vasquez United States

Simon Steiger Germany

Sylvia Snauwaert Belgium

Zuzana Chyra Czechia

Jessica Encinas Spain

Pia Sommerkamp Germany

Jung Hyun Her South Korea

Miriam Ritz Germany

Frank Frissora United States

Veronika Lysenko Switzerland

Michael Kilian

82 ×0.6

ONCOL

134 ×1.3

IMMUN

79 ×0.9

MB

45 ×0.7

GENET

66 ×1.1

HEMAT

Citations per year, relative to Michael Kilian Michael Kilian (= 1×) peers Veronika Lysenko

Countries citing papers authored by Michael Kilian

Since Specialization

Citations

This map shows the geographic impact of Michael Kilian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Kilian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Kilian more than expected).

Fields of papers citing papers by Michael Kilian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Kilian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Kilian. The network helps show where Michael Kilian may publish in the future.

Co-authorship network of co-authors of Michael Kilian

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Kilian. A scholar is included among the top collaborators of Michael Kilian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Kilian. Michael Kilian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

1.

Bunse, Lukas, Theresa Bunse, Michael Kilian, Francisco J. Quintana, & Michael Platten. (2025). The immunology of brain tumors. Science Immunology. 10(112). eads0449–eads0449. 1 indexed citations

2.

Friedrich, Mirco, Chris King, Chau-Duy-Tam Vo, et al.. (2025). Rational engineering of minimally immunogenic nucleases for gene therapy. Nature Communications. 16(1). 105–105. 15 indexed citations

3.

Friedrich, Mirco, Paola Neri, Simon Steiger, et al.. (2023). The pre-existing T cell landscape determines the response to bispecific T cell engagers in multiple myeloma patients. Cancer Cell. 41(4). 711–725.e6. 131 indexed citations breakdown →

4.

Kilian, Michael, Dirk C. Hoffmann, P. Koopmann, et al.. (2023). NLGN4X TCR transgenic T cells to treat gliomas. Neuro-Oncology. 26(2). 266–278. 9 indexed citations

5.

Zhao, Binghao, Michael Kilian, Theresa Bunse, Michael Platten, & Lukas Bunse. (2023). Tumor-reactive T helper cells in the context of vaccination against glioma. Cancer Cell. 41(11). 1829–1834. 5 indexed citations

6.

Kramer, Cynthia S. M., Michael Kilian, Khwab Sanghvi, et al.. (2023). P06.12.A NLGN4X-SPECIFIC TCR T CELLS TARGETING EXPERIMENTAL GLIOMAS. Neuro-Oncology. 25(Supplement_2). ii48–ii48. 1 indexed citations

7.

Kilian, Michael, Katrin Aslan, Khwab Sanghvi, et al.. (2022). T cell receptor dynamic and transcriptional determinants of T cell expansion in glioma-infiltrating T cells. Neuro-Oncology Advances. 4(1). vdac140–vdac140. 5 indexed citations

8.

Friedrich, Mirco, Markus Hahn, Roman Sankowski, et al.. (2022). Dysfunctional dendritic cells limit antigen-specific T cell response in glioma. Neuro-Oncology. 25(2). 263–276. 58 indexed citations

9.

Kilian, Michael, Sebastian Uhrig, Alexander Brobeil, et al.. (2022). IgE type multiple myeloma exhibits hypermutated phenotype and tumor reactive T cells. Journal for ImmunoTherapy of Cancer. 10(10). e005815–e005815. 5 indexed citations

10.

Kilian, Michael, Theresa Bunse, Wolfgang Wick, Michael Platten, & Lukas Bunse. (2021). Genetically Modified Cellular Therapies for Malignant Gliomas. International Journal of Molecular Sciences. 22(23). 12810–12810. 12 indexed citations

11.

Kilian, Michael, Chin Leng Tan, Katrin Aslan, et al.. (2021). Comparative evaluation of T-cell receptors in experimental glioma-draining lymph nodes. Neuro-Oncology Advances. 3(1). vdab147–vdab147. 2 indexed citations

12.

Kramer, Christopher M., Michael Kilian, Rainer Will, et al.. (2021). EXTH-28. NLGN4X TCR TRANSGENIC T CELLS TARGETING EXPERIMENTAL GLIOMAS. Neuro-Oncology. 23(Supplement_6). vi169–vi169. 1 indexed citations

13.

Kilian, Michael, et al.. (2021). Mass Spectrometric Quantification of the Antimicrobial Peptide Pep19-2.5 with Stable Isotope Labeling and Acidic Hydrolysis. Pharmaceutics. 13(9). 1342–1342. 2 indexed citations

14.

Zhang, Xinwen, Kristine Jähne, Frederik Cichon, et al.. (2021). Activity-regulated cytoskeleton-associated protein/activity-regulated gene 3.1 (Arc/Arg3.1) enhances dendritic cell vaccination in experimental melanoma. OncoImmunology. 10(1). 1920739–1920739. 3 indexed citations

15.

Tomek, Petr, Cristin G. Print, Michael A. Black, et al.. (2018). Imprinted and ancient gene: a potential mediator of cancer cell survival during tryptophan deprivation. Cell Communication and Signaling. 16(1). 88–88. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact